feed,title,long_url,short_url
SeekingAlpha,Goldman sees $80 oil before year-end despite likely return of Iran supply,https://seekingalpha.com/news/3699446,
SeekingAlpha,Dosing underway in Protagonist Therapeutics' early-stage study of PN-232,https://seekingalpha.com/news/3699445,
